Total Valuation
Carl Zeiss Meditec has a market cap or net worth of CHF2.63B. The enterprise value is CHF2.72K.
Market CapCHF2.63B
Enterprise ValueCHF2.72K
Share Statistics
Carl Zeiss Meditec has 89,440,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding89,440,570
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Carl Zeiss Meditec’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.50%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.50%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee385.14K
Profits Per Employee24.61K
Employee Count5,784
Asset Turnover0.64
Inventory Turnover2.12
Valuation Ratios
The current PE Ratio of Carl Zeiss Meditec is 18.1. Carl Zeiss Meditec’s PEG ratio is -1.32.
PE Ratio18.1
PS Ratio1.66
PB Ratio1.74
Price to Fair Value1.74
Price to FCF21.65
Price to Operating Cash Flow8.71
PEG Ratio-1.32
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.23B and earned 141.21M in profits. Earnings per share was 1.61.
Revenue2.23B
Gross Profit1.18B
Operating Income223.32M
Pretax Income193.89M
Net Income141.21M
EBITDA346.89M
Earnings Per Share (EPS)1.61
Cash Flow
In the last 12 months, operating cash flow was 300.27M and capital expenditures -27.76M, giving a free cash flow of 272.51M billion.
Operating Cash Flow300.27M
Free Cash Flow272.51M
Free Cash Flow per Share3.05
Dividends & Yields
Carl Zeiss Meditec pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.14
52-Week Price Change-82.78%
50-Day Moving Average28.07
200-Day Moving Average65.19
Relative Strength Index (RSI)73.53
Average Volume (3m)0.00
Important Dates
Carl Zeiss Meditec upcoming earnings date is Dec 10, 2026, TBA (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateDec 10, 2026
Ex-Dividend Date―
Financial Position
Carl Zeiss Meditec as a current ratio of 2.35, with Debt / Equity ratio of 0.00%
Current Ratio2.35
Quick Ratio1.44
Debt to Market Cap0.14
Net Debt to EBITDA1.67
Interest Coverage Ratio8.39
Taxes
In the past 12 months, Carl Zeiss Meditec has paid 51.55M in taxes.
Income Tax51.55M
Effective Tax Rate0.27
Enterprise Valuation
Carl Zeiss Meditec EV to EBITDA ratio is 12.31, with an EV/FCF ratio of 25.05.
EV to Sales1.92
EV to EBITDA12.31
EV to Free Cash Flow25.05
EV to Operating Cash Flow20.35
Balance Sheet
Carl Zeiss Meditec has CHF23.90M in cash and marketable securities with CHF0.00 in debt, giving a net cash position of CHF23.90M billion.
Cash & Marketable SecuritiesCHF23.90M
Total DebtCHF0.00
Net CashCHF23.90M
Net Cash Per ShareCHF0.27
Tangible Book Value Per ShareCHF5.66
Margins
Gross margin is 51.04%, with operating margin of 10.02%, and net profit margin of 6.34%.
Gross Margin51.04%
Operating Margin10.02%
Pretax Margin8.70%
Net Profit Margin6.34%
EBITDA Margin15.57%
EBIT Margin9.90%
Analyst Forecast
The average price target for Carl Zeiss Meditec is CHF25.33, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetCHF25.33
Price Target Upside-14.99% Downside
Analyst ConsensusModerate Sell
Analyst Count10
Revenue Growth Forecast-2.34%
EPS Growth Forecast-40.09%